COMP <GO>
NEPH vs TELA // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Nephros Inc. (NASDAQ) VS. TELA Bio Inc. (NASDAQ) • 15-METRIC TALLY: NEPH 6
— TELA 2
■ METRIC PARITY
LAST: $3.24 (+2.21%) • MKT CAP: $34.5M
options-implied-move
—
LAST: $0.80 (-1.33%) • MKT CAP: $36.6M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEPH VS. TELA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEPH | TELA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.90% | 67.70% | -5.80 | TELA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.90% | -35.00% | +53.90 | NEPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.50% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 6.10% | -42.00% | +48.10 | NEPH | /operating-margins <GO> |
| Net Profit Margin | 6.40% | -48.30% | +54.70 | NEPH | /net-margins <GO> |
| Revenue Growth (YoY) | 32.70% | 15.80% | +16.90 | NEPH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | NEPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.0 | 37.6 | +0.40 | NEPH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $34.5M | $36.6M | -$2.1M | TELA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEPH REV | TELA REV | NEPH GROSS % | TELA GROSS % | NEPH FCF | TELA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.8M | $80.3M | 61.9% | 67.7% | $1.6M | -$28.7M |
| FY 2024 | $14.2M | $69.3M | 61.6% | 67.1% | -$547.0K | -$42.6M |
| FY 2023 | $14.2M | $58.5M | — | — | $827.0K | -$40.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEPH // BETA —
TELA // BETA —